Vaccine for falciparum malaria
The invention provides compositions and methods for preventing or reducing the severity of malaria.
1. A method of treating P. falciparum malaria in a subject or vaccinating against malaria comprising administering to the subject a composition comprising a purified PfGARP polypeptide antigen comprising the amino acid sequence of SEQ ID NO: 27 or a purified antigenic fragment thereof comprising the amino acid sequence of SEQ ID NO: 26.
2. The method of claim 1 , wherein said purified antigen or antigenic fragment thereof comprising the amino acid sequence of SEQ ID NO: 26 elicits an antibody immune response against PfGARP.
3. The method of claim 1 , wherein said subject is at least about 6-8 weeks of age.
4. The method of claim 1 , wherein said subject is an adolescent female or a female of childbearing age.
5. The method of claim 1 , wherein said composition is administered intramuscularly.
6. The method of claim 1 , further comprising administering a second vaccine.
7. The method of claim 6 , said second vaccine comprises RTS,S (Mosquirix) or MSP-1.